Share
Other content recommended for you
- Endangerment of the iPSC stock project in Japan: on the ethics of public funding policies
- What are considered ‘good facts’?
- Cell and organ bioengineering technology as applied to gastrointestinal diseases
- Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
- Current outlook of cardiac stem cell therapy towards a clinical application
- Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
- Embryo as epiphenomenon: some cultural, social and economic forces driving the stem cell debate
- News
- In vitro eugenics
- Advances in regenerative medicine for otolaryngology/head and neck surgery